Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus Fractures
Launched by THE COOPER HEALTH SYSTEM · Nov 14, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how long patients should be kept in a sling after having surgery for a specific type of shoulder fracture, known as a proximal humerus fracture. The researchers want to find out if patients who are allowed to move their shoulder early, with just a sling for comfort, recover better than those who are kept in a sling for four weeks and can only move their shoulder with assistance.
To join the study, participants must be 60 years or older and have a displaced proximal humerus fracture that requires a surgical procedure called reverse total shoulder arthroplasty, which is a type of shoulder replacement surgery. Patients will be randomly assigned to one of the two groups, and they can expect to follow their assigned rehabilitation plan after surgery. This trial is currently recruiting participants, and it aims to help improve recovery outcomes for older adults with these types of shoulder injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients 60 years or older who have a displaced proximal humerus fracture
- • Meets surgical criteria for a reverse total shoulder arthroplasty
- • Receive surgical intervention within 6 weeks of initial injury
- Exclusion Criteria:
- • Patients \<60 years in age
- • Patients who cannot undergo surgery due to medical comorbidities
- • Patients who receive surgical intervention after 6 weeks from initial injury
- • Patients who have preoperative nerve damage from their fractures that would limit the ability to move the arm postoperatively
About The Cooper Health System
The Cooper Health System is a leading academic healthcare organization dedicated to delivering high-quality clinical care, advancing medical research, and providing education in the health sciences. With a robust network of hospitals, outpatient facilities, and specialized care centers, Cooper is committed to improving patient outcomes through innovative treatments and cutting-edge clinical trials. The system's research initiatives focus on a wide range of medical disciplines, fostering collaboration among healthcare professionals and academic institutions to enhance evidence-based practices and contribute to the advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Camden, New Jersey, United States
Patients applied
Trial Officials
Catherine J Fedorka, MD
Principal Investigator
Cooper Hospital Orthopedic Surgery
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported